Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- International Institute of Molecular and Cell Biology in Warsaw
- RMIT University
- Uppsala University
- ;
- Duke University
- Karolinska Institutet
- Radboud University Medical Center (Radboudumc)
- Technical University of Munich
- University of Louisville
- University of Oslo
- ; University of Southampton
- ; University of Warwick
- Academic Europe
- CNRS
- Ilya Pharma
- Institute of Physical Chemistry, Polish Academy of Sciences
- Johannes Gutenberg University Mainz •
- Leibniz
- Linköping University
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Denmark
- University Medical Centre Groningen (UMCG)
- University of Basel
- University of Florida
- University of Massachusetts Medical School
- University of Pittsburgh
- Université de Caen Normandie
- 18 more »
- « less
-
Field
-
Team is to develop a highly effective therapeutic mRNA design and apply it for cancer immunotherapy. The Research Task will be carried out by a team of scientists from the IIMCB (coordinator
-
lipids, offering potential tumor biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks
-
such as radio-immunotherapy. Image analysis, programming and use of clinical software’s for treatment planning will be central components of the work. The project will concern both photon and particle
-
TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz • | Mainz, Rheinland Pfalz | Germany | 2 days ago
programme No Joint degree / double degree programme No Description/content BioNTech and TRON (Translational Oncology Mainz) are leading institutions in the field of immunotherapy. Our joint international PhD
-
unknown chemokine can be used when developing next generation immunotherapies. Requirements Research FieldMedical sciencesEducation LevelMaster Degree or equivalent Skills/Qualifications Profile We
-
therapeutically in combination with novel immunotherapies. Here at the Duke Human Vaccine Institute, we value collaborations, and pride ourselves in providing an excellent environment for academic and professional
-
Signals in Cancer” (Head: Prof. Dr. med. Jürgen Ruland) is to (i) explore the molecular mechanisms and pathways that drive immune dysfunction and immunotherapy resistance, (ii) modulate cancer
-
Immunotherapy, Cancer Therapeutics, Cancer Virology, and Genome Stability. Successful candidate will have a PhD or equivalent in Biostatistics, Statistics, or related field with ability to work collaboratively
-
expression of key molecules that may be important to ovarian cancer immunotherapy and have wider implications for the treatment of chronic disease. Hypothesis: Xanthatin and/or carnosine modulate anti-cancer
-
criteria: Interest in and ability to work in an interdisciplinary setting, including with scientists and/or engineers. Experience in metallo-compound, cancer or immunotherapy research. Current treatments